See every side of every news story

Published 1 year ago • loading... • Updated 1 year ago

Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

Summary by Watauga Democrat

SHANGHAI, June 15, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective small molecule FGFR4 inhibitor, for the treatment of Hepatocellular Carcinoma…

82 Articles

82 Articles

Cherokee Tribune Ledger News

Watauga Democrat

Charleston Gazette-Mail

WBOC 16

Delaware Business Now

Local 3 News

Rutland Herald

ashepostandtimes.com

NNY360

The Berkshire Eagle

Brattleboro Reformer

TBNweekly

Bennington Banner

The Laconia Daily Sun

The Coal Valley News

waynecountynews.com

williamsondailynews.com

The Logan Banner

Islander News

coasttv.com

Queens Chronicle

Appalachian News-Express

The Times-News

Record Argus - Serving Greenville, PA since 1848

The Progress

The State Journal

coastaltvnews.com

LoudounTimes.com

MyHorryNews.com

Suncoast News

therogersvillereview.com

blockislandtimes.com

The Westerly Sun

Hometown News Brevard

The Avery Journal-Times

The Advocate & Democrat

The Dispatch

Hometown News Treasure Coast

The Daily Press

Essex Reporter

mainstreetnews.com

Loudoun Now

The Ridgway Record

The Clarion News

delmarvasportsnetwork.com

Observer News Enterprise

The Transylvania Times

The Caswell Messenger

Lincoln Times News

Carroll News

Independent-Messenger

SRI News

Alex City Outlook

Brunswicktimes Gazette

Herald Chronicle

thesussexsurrydispatch.com

willistonobserver.com

miltonindependent.com

Rappahannock News

Selma Sun

thepilotnews.com

Daytona Times

Community News

Fairfax County Times

Westminster Cable Network

The Miami Times

theohiopressnetwork.com

upstatetoday.com

Florida Courier

winchesternewsgazette.com

The Inquirer and Mirror

kentuckytoday.com

dailytimesleader.com

Times Virginian

Oswego County News Now

mountaineagle.com

The News Progress

Altavista Journal

miltontimes.com

www.Arundel.News

swrankinnews.com

Coastal Point

+81 Reposted by 81 other sources

Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

SHANGHAI, June 15, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective small molecule FGFR4 inhibitor, for the treatment of Hepatocellular Carcinoma…

1 year ago·Cherokee County, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Similar News Topics